Afuco™ Anti-IL23A ADCC Therapeutic Antibody (Guselkumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human IL23A. Guselkumab is a monoclonal antibody designed for the treatment of psoriasis.
Supplier Creative Biolabs
Product # AFC-TAB-752
Pricing Inquiry
Host Human
Target IL23A
Species Reactivity Human
Type ADCC enhanced antibody
Applications Neut, ELISA, IF, IP, FuncS, FC
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback